FI52089C - Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. - Google Patents

Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia.

Info

Publication number
FI52089C
FI52089C FI129371A FI129371A FI52089C FI 52089 C FI52089 C FI 52089C FI 129371 A FI129371 A FI 129371A FI 129371 A FI129371 A FI 129371A FI 52089 C FI52089 C FI 52089C
Authority
FI
Finland
Prior art keywords
benzo
preparation
therapeutically active
naphthyridine derivatives
active cis
Prior art date
Application number
FI129371A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI52089B (forum.php
Inventor
Hans Ott
Rudolf Sueess
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH708670A external-priority patent/CH527196A/de
Priority claimed from CH708970A external-priority patent/CH527822A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of FI52089B publication Critical patent/FI52089B/fi
Publication of FI52089C publication Critical patent/FI52089C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI129371A 1970-05-13 1971-05-11 Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. FI52089C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH708670A CH527196A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphthyridinderivate
CH708970A CH527822A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate

Publications (2)

Publication Number Publication Date
FI52089B FI52089B (forum.php) 1977-02-28
FI52089C true FI52089C (fi) 1977-06-10

Family

ID=25700728

Family Applications (1)

Application Number Title Priority Date Filing Date
FI129371A FI52089C (fi) 1970-05-13 1971-05-11 Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia.

Country Status (14)

Country Link
JP (1) JPS5432799B1 (forum.php)
AT (1) AT326674B (forum.php)
CA (1) CA970377A (forum.php)
CS (2) CS162753B2 (forum.php)
DE (1) DE2123328A1 (forum.php)
DK (1) DK134488B (forum.php)
ES (1) ES391026A1 (forum.php)
FI (1) FI52089C (forum.php)
FR (1) FR2100649B1 (forum.php)
GB (1) GB1361441A (forum.php)
NL (1) NL7106502A (forum.php)
PL (1) PL76913B1 (forum.php)
SE (1) SE387640B (forum.php)
SU (1) SU423296A3 (forum.php)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
NL7314396A (forum.php) * 1972-10-26 1974-05-01
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine
US6384047B1 (en) 1997-06-03 2002-05-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
KR100701904B1 (ko) 1999-08-21 2007-04-02 알타나 파마 아게 Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
BRPI0510951A (pt) * 2004-05-12 2007-11-20 Pfizer Prod Inc derivados de piperidina como antagonistas de nk1 e nk3
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2012223337C1 (en) 2011-03-01 2016-11-10 Bausch Health Ireland Limited Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Also Published As

Publication number Publication date
PL76913B1 (en) 1975-02-28
FR2100649A1 (forum.php) 1972-03-24
AT326674B (de) 1975-12-29
NL7106502A (forum.php) 1971-11-16
SU423296A3 (ru) 1974-04-05
FI52089B (forum.php) 1977-02-28
CA970377A (en) 1975-07-01
DK134488B (da) 1976-11-15
ES391026A1 (es) 1974-04-01
GB1361441A (en) 1974-07-24
DE2123328A1 (de) 1971-12-02
CS167202B2 (forum.php) 1976-04-29
JPS5432799B1 (forum.php) 1979-10-16
FR2100649B1 (forum.php) 1974-08-30
DK134488C (forum.php) 1977-05-16
ATA412471A (de) 1975-03-15
CS162753B2 (forum.php) 1975-07-15
SE387640B (sv) 1976-09-13

Similar Documents

Publication Publication Date Title
FI52089C (fi) Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia.
NO140301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
FI49300C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
FI49515C (fi) Menetelmä farmakologisesti vaikuttavien 11-asemaan substituoitujen 5,1 1-dihydro-6H-pyrido/2,3-b//1,4/bentsodiatsepiini-6-onien valmistamisek si.
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
FI48588C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi.
NO741744L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin.
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
FI49504C (fi) Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi.
PH12247A (en) Pharmaceutically active compounds
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
NO741752L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner.
NO136574C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI51349C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi.
NO741044L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner.
FI49514C (fi) Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi.
FI50630C (fi) Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi.
FI50629C (fi) Menetelmä uusien terapeuttisesti aktiivisten 2,3-dihydro-1H-tieno-bent sotiepino(4,5-c)pyrroli-yhdisteiden valmistamiseksi.
FI47357C (fi) Menetelmä terapeuttisesti vaikuttavien 4'-demetyyli-epipodofyllotoksii ni-beta-D-glukosidin johdannaisten valmistamiseksi.
NO742973L (no) Kjemisk mellomprodukt for bruk ved fremstilling av terapeutisk aktive 2,6-metan-3-benzazosiner.
FI50875C (fi) Menetelmä terapeuttisesti aktiivisten dihydro-2-aminoisokinoliinien va lmistamiseksi.